asthma

By Heather Mack February 8, 2017
Digital respiratory health management company Propeller Health is collaborating with Novartis to develop a custom add-on sensor for the Swiss pharmaceutical company’s Breezhaler inhaler, which is used for Novartis’s portfolio of COPD treatments. The partnership will be focused in Europe. The add-on sensor will be developed to work with the capsule-based dry powder inhaler by passively recording...
By Jonah Comstock November 17, 2016
Correction: A previous version of this article misstated the adherence figure.  Adherium’s Smartinhaler has been shown to increase medication adherence by 43 percent and reduce hospitalization by a factor of five, according to a new study conducted at Sheffield Children’s Hospital in the UK and published in the journal Thorax. The randomized control trial included 77 children with asthma. “This...
By Heather Mack November 7, 2016
Madison, Wisconsin-based Propeller Health, maker of several smart inhaler sensors and companion apps, has received FDA 510(k) clearance for its latest offering – a sensor that works with GlaxoSmithKline’s Ellipta inhaler. This marks the company’s eighth FDA clearance, and was born out of a partnership the company struck up with GSK last December. Given Propeller's growing familiarity with the...
By Jonah Comstock August 22, 2016
Asthma UK, a British nonprofit dedicated to fighting asthma, has released a report highlighting the role connected health has to play in treating asthma and reducing the number of preventable deaths from the disease.  "At Asthma UK we are determined to stop asthma attacks." Asthma UK CEO Kay Boycott writes in the introduction to the report. "Outcomes have plateaued in recent years and this must...
By Jonah Comstock July 20, 2016
Adherium, a Melbourne, Australia-based connected inhaler company, has raised $5.9 million ($8 million Australian) through a private placement of shares with Fidelity. Adherium is publicly traded in Australia. Under the deal, Fidelity will purchase 16 million shares at $0.50 Australian per share, bringing the global asset manager's share in the company to 10 percent. “Fidelity International are...
By Heather Mack July 14, 2016
At the Wearable Technologies conference in San Francisco this week, companies presented several devices they said were primed for widespread distribution across healthcare and fitness industries, but were also in search of additional investors as well as partnerships with payers and providers to make it happen.   Here’s a round-up of some of the devices that took the stage:  BioRibbon Perhaps the...
By Heather Mack June 30, 2016
Wing, an app-connected spirometer from St. Louis, Missouri-based Sparo Labs, is ready to take flight. The FDA recently cleared the device with an over-the-counter clearance, meaning the company can market it directly to consumers, but Sparo sees provider and pharma channels as important ones too.  With Wing, Sparo aims to help people manage asthma and other respiratory conditions, such as COPD...
By Jonah Comstock April 22, 2016
Propeller Health’s connected inhaler technology helped to reduce usage of a rescue inhaler in a recent study of 495 asthma patients conducted at Dignity Health.  “The research demonstrates that the benefits of telehealth go beyond monitoring medication adherence, but can also identify patterns of risk and impairment. This additional information may allow more timely interventions and enhanced...
By Aditi Pai April 20, 2016
Australia-based ResApp, a public company, has raised $9.74 million ($12.5 million Australian dollars) for its product, a smartphone-based system for diagnosing respiratory conditions. The company sold 62.5 million new ordinary shares at $0.16 ($0.20 AU) per share. ResApp’s offering essentially uses the smartphone microphone as a stethoscope to listen to a patient’s breathing. But instead of...
By Jonah Comstock April 4, 2016
A smartphone-based system for diagnosing respiratory diseases achieved an accuracy of 89 percent in a recent clinical study of 524 pediatric patients conducted by the company at Joondalup Health Campus (JHC) and Princess Margaret Hospital (PMH) in Perth, Western Australia. Perth-based ResApp essentially uses the smartphone microphone as a stethoscope to listen to a patient’s breathing. But...